Share this page

 AVYOMA PHARMA — 2499593

Toolbar

Toolbar

Details

Third-party disclaimer

Share this page

No endorsement of any products or services is expressed or implied.

Third-party disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Application number

2499593

Type(s)

Standard Characters

Category

Trademark

CIPO Status

FORMALIZED

TM5 status

LIVE/APPLICATION/ Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.

Filed

2026-09-08

Applicant

17989377 Canada Inc.
2500-1100 Boul René-Lévesque O
Montréal
QUÉBEC H3B5C9

Agent

DECODE LEGAL
560 boul. Crémazie Est
3e étage
Montréal
QUEBEC H2P1E8

Documents

View documents

Index headings

  • AVYOMA PHARMA

Goods (Nice class & Statement)

5
(1) Pharmaceutical preparations in the form of tablets, capsules, oral solutions and suspensions, oral powders and granules, oral dissolving films and sublingual films, solutions, suspensions and emulsions for injection or infusion, lyophilisates for reconstitution and injection, transdermal patches, creams, ointments, gels and lotions for topical application, aerosols, powders and solutions for inhalation, ophthalmic drops, gels and ointments, nasal solutions, sprays and gels, suppositories and rectal preparations, vaginal preparations, preparations delivered by pump systems for the treatment of cardiovascular diseases, of haematological diseases and blood disorders, of oncological and hemato-oncological diseases, of infectious diseases, namely, bacterial, viral, fungal and parasitic infections, of diseases of the central and peripheral nervous system, of mental and behavioural disorders, of respiratory diseases, of endocrine, nutritional and metabolic diseases, of gastrointestinal and hepatic diseases, of renal and urological diseases, of musculoskeletal and rheumatic diseases, of dermatological diseases, of ophthalmic diseases, of ear, nose and throat diseases, of gynaecological and obstetric diseases, of diseases in paediatric patients, of rare and orphan diseases, for pain management and palliative care, of immune system disorders and autoimmune diseases.

Action History

Actions
Action Action date Due date Comments
Filed 2026-09-08
Created 2026-09-08
Formalized 2026-09-08
Report a problem on this page
Date modified: